Beaker List 🔬 - Top 23 Female Academic Entrepreneurs Happy International Women's Day! 🙌 To honor the women worldwide who are transforming the Life Sciences field daily, we are proud to announce the release of a special edition of our Beaker List, featuring 23 female academic entrepreneurs who have made groundbreaking strides in research. Overview Behind every transformative technology is a team of brilliant scientists and researchers. Academic research in particular is a driving force for technological innovation. Here, we have identified a ‘Midas List’ of researchers who have pioneered highly transformative technologies that have translated to the clinic. Using venture backed startups as a primary guide along with other impact metrics such as patents, citations, and thought leadership, the following professors have demonstrated patient impact, providing significant contributions to the startup ecosystem. The Life Sciences ecosystem is experiencing unprecedented innovation, and academic entrepreneurs are at the forefront of this change. Women’s History Month is a time to celebrate women past and present from all walks of life. In honor of International Women’s Day 2023, we at BIOS have the pleasure of putting together the “Top 23 Women in Academic Entrepreneurship” that have truly changed the life sciences ecosystem as we know it. In honor of International Women’s Day 2023 taking place on 3 / 8 / 23, this list features 3 categories to commemorate the date… 3: Stars Amongst Stars - 3 star academic entrepreneurs who have changed the face of research & impacted patients on the highest of levels ❤️ 8: Leading Innovators - 8 academic entrepreneurs who are on the cutting edge of life sciences research 🔬 23: Entrepreneurs to Follow - 23 of today’s top translational researchers 🎉 These women are pioneers shaping translational research and inspiring today's medical miracles, demonstrating patient impact. Through their work, these women are shaping the future of medicine and inspiring the next generation of academic entrepreneurs. From groundbreaking discoveries to entrepreneurial leadership, this article showcases in alphabetical order the impressive accomplishments of these pioneering women and their vital role in the Life Science startup landscape. Shoutout to these amazing innovators: Angela Belcher, Anna Marie Pyle, Barbara Slusher, Carolyn Bertozzi, Christina Smolke, Elaine Hsiao, Elizabeth Blackburn, Frances Arnold, Gordana Vunjak-Novakovic, Jennifer Cochran, Jennifer Doudna, Jennifer Elisseeff, Jennifer Lewis, Lili Yang, Nicole F. Steinmetz Ph.D., Mary (Nora) Disis, Pamela Silver, Sangeeta Bhatia, Shana Kelley, Stephanie Cherqui, Viviana Gradinaru Click below to access this special edition list... http://ow.ly/2uZm50NbGEo #startups #lifesciences #genomics #research #biology #science #healthcare #innovation #engineering #founders #syntheticbiology #startup #pharma #entrepreneurship #patientimpact #phd #VC
BIOS
Biotechnology
San Francisco, California 6,453 followers
Uniting the Life Science Ecosystem In #PatientImpact ❤️ — Highlighting Leaders Shaping The Future Of Medicine ✨
About us
The Nucleus of Life Science Innovation — By Alix Ventures _______________________________ Alix Ventures, by way of BIOS Community, is providing this content for general information purposes only. Reference to any specific product or entity does not constitute an endorsement or recommendation by Alix Ventures, BIOS Community, or its affiliates. The views expressed by guests are their own and their appearance on the program does not imply an endorsement of them or any entity they represent. Views and opinions expressed by Alix Ventures employees are those of the employees and do not necessarily reflect the view of Alix Ventures, BIOS Community, affiliates, and content sponsors.
- Website
-
https://bioscommunity.com
External link for BIOS
- Industry
- Biotechnology
- Company size
- 2-10 employees
- Headquarters
- San Francisco, California
- Type
- Privately Held
- Founded
- 2020
- Specialties
- Life Sciences, Venture Capital, Startups, Thought Leadership, Community, Pharma, Professors, PhD, Founders, and Innovation
Locations
-
Primary
San Francisco, California 94158, US
Employees at BIOS
Updates
-
BIOS Talent: Weekly Update 🌟 World’s 1st TechBio Job Board / Weekly Newsletter🧬 BIOS Talent— A first-of-its-kind job board centralizing the real-time openings of today’s leading TechBio Startups. The Life Science sector with the rise of TechBio \(A melding of technology & biology\) is experiencing unprecedented innovation, a change we believe is leading to some of the most impactful solutions in decades. BIOS has compiled the largest centralized TechBio job board to help you uncover the best opportunities within the ecosystem. Featuring the world’s leading builders on the cutting edge of life-saving innovations search from over 300+ companies & discover over 4000+ TechBio job openings… Click below to learn more...
BIOS Talent: World’s 1st TechBio Job Board / Weekly Newsletter 🧬
bioscommunity.substack.com
-
🎙️ Biophysics and Rejuvenation w/ Stephen Quake- Professor @ Stanford Thrilled to re- share our podcast episode featuring the renowned Stephen Quake, co-President of the Chan Zuckerberg Biohub and Professor at Stanford University. We delve into his fascinating journey from physics to bioengineering, exploring how his pioneering work is revolutionizing early cancer detection through liquid biopsies. Stephen shares his insights on the lessons learned from the Theranos scandal, emphasizing the importance of integrity and scientific rigor in the biotech industry. We also discuss his involvement with Veblen and the Eleftheria Foundation, two organizations at the forefront of driving innovative solutions for global health challenges. This episode is packed with valuable takeaways for entrepreneurs, scientists, and anyone passionate about the future of life sciences. Tune in:
37. Biophysics & Rejuvenation w/ Stephen Quake - Professor @ Stanford / Co-President @ Chan Zuckerberg Biohub
https://spotify.com
-
Deep Dive: Drug Repurposing & Reengineering The innovative field of #DrugRepurposing and #Reengineering is transforming biopharma by breathing new life into existing drug compounds. This approach leverages our advanced understanding of network and systems biology, along with cutting-edge technologies like #AI and #ComputationalBiology, to uncover new uses for drugs that have already been through rigorous clinical testing. By bypassing early trial phases, these repurposed drugs can move directly to Phase II trials, significantly reducing development costs and time to market. This not only provides a quicker route to effective treatments but also addresses the urgent needs in underserved disease areas. Dive into our latest article to explore how medium and large biopharma companies are harnessing these strategies to deliver innovative solutions and improve patient outcomes globally. Tune in:
Deep Dive #5: Drug Repurposing & Reengineering
bioscommunity.substack.com
-
BIOS Talent: Weekly Update 🌟 World’s 1st TechBio Job Board / Weekly Newsletter🧬 BIOS Talent— A first-of-its-kind job board centralizing the real-time openings of today’s leading TechBio Startups. The Life Science sector with the rise of TechBio \(A melding of technology & biology\) is experiencing unprecedented innovation, a change we believe is leading to some of the most impactful solutions in decades. BIOS has compiled the largest centralized TechBio job board to help you uncover the best opportunities within the ecosystem. Featuring the world’s leading builders on the cutting edge of life-saving innovations search from over 300+ companies & discover over 4000+ TechBio job openings… Click below to learn more... https://buff.ly/4ap04RQ
BIOS Talent: World’s 1st TechBio Job Board / Weekly Newsletter 🧬
bioscommunity.substack.com
-
🧱 Builders w/ Maddison Masaeli - Co-Founder & CEO @ Deepcell 🚀 Excited to share our latest podcast episode featuring Maddison Masaeli, Co-founder & CEO of @Deepcell! In this insightful conversation, Maddison delves into Deepcell’s innovative approach to single-cell imaging and analysis, shedding light on their groundbreaking technology and its transformative impact on diagnostic testing and therapeutics. Discover how their ambitious project is building the world’s largest database of cellular morphologies and explore the future of precision medicine. Don’t miss this chance to gain valuable insights into the cutting-edge developments shaping the future of healthcare. 🎧 Tune in:
Builders #10 w/ Maddison Masaeli - Co-Founder & CEO @ Deepcell | BIOS
https://www.youtube.com/
-
Deep Dive: Longevity Therapeutics 🌟 Exciting developments in the field of longevity therapeutics! Unity Biotech’s Phase II trial for osteoarthritis could be a game-changer in senolytic therapies. This innovative compound targets and eliminates senescent cells, potentially improving quality of life and healthspan. Additionally, the ongoing study of dasatinib and quercetin (D+Q) is showing promising results in removing senescent cells. The big question remains: will these interventions translate to tangible health benefits? Dive into our detailed article to explore the potential future impact of these groundbreaking research efforts on aging and longevity interventions. Read more: https://buff.ly/4cf9P5v #Longevity #AgingResearch #Healthspan #Senolytics #BiotechInnovation #ClinicalTrials
Deep Dive #6: Longevity Therapeutics
bioscommunity.substack.com
-
Frontier Science - Advanced Microfluidics✨ w/ Albert Folch - Professor University of Washington We are thrilled to re-share our episode on BIOS Frontier Science, featuring Albert Folch, Associate Professor of Bioengineering at the University of Washington. Join us as we delve into the revolutionary world of microfluidic devices and explore how Albert Folch's team is pushing the boundaries of bioengineering through innovative 3D printing and automation techniques. From improving cancer diagnostics to pioneering cellular micropatterns, this episode is packed with insights on the future of this dynamic field. Tune in to gain a deeper understanding of the challenges and opportunities in microfluidics and hear Albert's vision for the next decade. Don't miss this enlightening conversation—click the link to listen now! Tune in: https://buff.ly/3A6xdEz #Bioengineering #Microfluidics #Innovation #SciencePodcast #FutureTech
Frontier Science #6 - Advanced Microfluidics✨ w/ Albert Folch - Professor @ UW | BIOS
https://www.youtube.com/
-
BIOS Talent: Weekly Update 🌟 World’s 1st TechBio Job Board / Weekly Newsletter🧬 BIOS Talent— A first-of-its-kind job board centralizing the real-time openings of today’s leading TechBio Startups. The Life Science sector with the rise of TechBio \(A melding of technology & biology\) is experiencing unprecedented innovation, a change we believe is leading to some of the most impactful solutions in decades. BIOS has compiled the largest centralized TechBio job board to help you uncover the best opportunities within the ecosystem. Featuring the world’s leading builders on the cutting edge of life-saving innovations search from over 300+ companies & discover over 4000+ TechBio job openings… Click below to learn more...
BIOS Talent: World’s 1st TechBio Job Board / Weekly Newsletter 🧬
bioscommunity.substack.com
-
🧱 Builders w/ Eric Kelsic - Co-Founder & CEO @ Dyno Therapeutics Dive deep into the future of gene therapies as Eric discusses the innovative CapsidMap™ platform, which uses AI to optimize AAV capsids for better targeting, payload size, immune evasion, and manufacturability. Learn about the cutting-edge techniques Dyno employs, including DNA library synthesis, high-throughput measurement, and machine learning models, to revolutionize viral vector development and advance the field of gene therapy. Eric also shares the challenges and successes faced by Dyno, their $100M Series A funding, and the transformative potential of their technology. Whether you're a biotech enthusiast, a researcher, or just curious about the future of medicine, this episode is packed with insights and visionary perspectives. Don't miss out—tune in now to discover how Dyno Therapeutics is shaping the future of gene therapy! Tune in:
Builders #9 w/ Eric Kelsic - Co-Founder & CEO @ Dyno Therapeutics | BIOS
https://www.youtube.com/